Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives

Alzheimer’s disease is a progressive, clinically heterogeneous, and particularly complex neurodegenerative disease characterized by a decline in cognition. Over the last two decades, there has been significant growth in the investigation of cerebrospinal fluid (CSF) biomarkers for Alzheimer’s diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: McGrowder, Donovan A., Miller, Fabian, Vaz, Kurt, Nwokocha, Chukwuemeka, Wilson-Clarke, Cameil, Anderson-Cross, Melisa, Brown, Jabari, Anderson-Jackson, Lennox, Williams, Lowen, Latore, Lyndon, Thompson, Rory, Alexander-Lindo, Ruby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916561/
https://www.ncbi.nlm.nih.gov/pubmed/33578866
http://dx.doi.org/10.3390/brainsci11020215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916561/
https://www.ncbi.nlm.nih.gov/pubmed/33578866
http://dx.doi.org/10.3390/brainsci11020215

Ejemplares similares